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Schistosoma haematobium is a para-sitic flatworm that infects millions of 
people, mostly in the developing world, 
and is associated with high incidence of 
bladder cancer although why is not clear. 
But our group was able to define the 
mechanistic relationship for the first time 
between infection of S. haematobium 
and cancer. We used in vitro models to 
demonstrate the presence of informative 
carcinogenesis-associated phenotypes in 
CHO cells exposed to Sh total antigen, 
in which we showed increased cell pro-
liferation, decreased apoptosis, upregula-
tion of the anti-apoptotic molecule Bcl-2, 
downregulation of the tumor suppressor 
protein p27, and increased cell migration 
and invasion.
We further discuss the molecular and 
cellular events that might be respon-
sible for schistosomiasis-related bladder 
cancer.
Schistosomiasis, also known as snail 
fever—since part of the parasite life cycle 
occurs in these animals—is a potential 
fatal disease that, according to the World 
Health Organization, infects 200 million 
people and is endemic in as much as 76 
tropical developing countries. The dis-
ease, spread through contaminated waters, 
is only second to malaria in rates of infec-
tion and public health impact throughout 
the developing world, but has been one of 
many neglected tropical diseases until very 
recently, when globalization and its associ-
ated intense migration flux has brought it 
into the light. And infection by S. hae-
matobium—a member of this family—is 
particularly relevant due to its association 
to bladder cancer. In fact, in some of the 
regions where S. haematobium is endemic, 
bladder cancer is the most common can-
cer in men and the second in women, just 
behind breast cancer, accounting for as 
much as 30% of all cancer cases.1
In an attempt to understand this wor-
rying link between infection and cancer 
our group exposed cells growing in labora-
tory to extracts of S. haematobium look-
ing for changes, particularly in those traits 
associated with cancerous processes. In 
fact, cancer cells can be defined by rapid 
uncontrolled division, high resistance to 
death and—in the late stages of the dis-
ease—an abnormal capability to migrate 
through tissues (normal cells, except for 
a few exceptions, are not capable of move 
out of their “home” tissue/organ). We 
found that, in fact, cells exposed to S. hae-
matobium cells divided faster and more 
than those not exposed to the parasite, 
and also died much less. When searching 
for molecular clues to explain such altera-
tions it was found that the altered cells pre-
sented increased levels of bcl2—a protein 
involved in cellular death and linked to 
cancer—while the tumor suppressor pro-
tein p27 was reduced. These cells were also 
more mobile than controls, a crucial char-
acteristic for metastasis formation. These 
results revealed S. haematobium is able to 
induce the formation of cancer-like cells.2
Next, in a second study we injected 
S. haematobium—exposed cells into mice 
with no immune system and, remark-
ably, this led to tumors very similar to 
those found in bladder cancer. Crucially, 
animals injected with non-exposed cells 
showed no growths (Fig. 1).3
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We have further used a CD-1 mice 
model to show that Schistosoma haemato-
bium total antigen (Sh) has a carcinogenic 
ability. Intravesically administration of Sh 
gave rise to a high incidence of urothelial 
dysplasia (Fig. 2).4
The urothelium of the animals exposed 
to Sh described in this paper presented sim-
ilar phenotypes. The urothelium of these 
animals presented dysplasia (LGIUN—
Low Grade Intra-Urothelial Neoplasia), 
a non-invasive malignant flat lesion, in 
70% of the tested subjects after 40 weeks 
of treatment (Table 1, Fig. 3). Our results 
suggest that Sh induce the malignization 
of the urothelium.5
Although squamous cell carcinoma of 
the urinary bladder has been associated 
with Schistosoma haematobium infection 
in many parts of Africa, the cellular and 
molecular mechanisms linking S. haema-
tobium infection with cancer formation 
are not yet defined. Carcinoma of the blad-
der frequently harbours gene mutations 
that constitutively activate the receptor 
tyrosine kinase-Ras pathway.6 The ras-sig-
naling pathway has attracted considerable 
attention as a target for anticancer therapy 
because of its important role in carcino-
genesis. The Ras gene product is a mono-
meric membrane-localized G protein of 
21 kd that functions as a molecular switch 
linking receptor and nonreceptor tyrosine 
kinase activation to downstream cytoplas-
mic or nuclear events. Each mammalian 
cell contains at least three distinct ras 
proto-oncogenes encoding closely related, 
but distinct proteins, Kras, Hras and Nras 
Activating mutations in these Ras proteins 
result in constitutive signaling, thereby 
stimulating cell proliferation and inhibit-
ing apoptosis. Oncogenic mutations in the 
ras gene are present in approximately 30% 
of all human cancers.7 In our latest study 
we used the dysplastic bladders induced 
by Sh and screened them by sequencing 
Figure 1. Analysis of the tumour volume induced by control CHO and Sh treated CHO in nude 
mice. Tumour volumes were measured at the indicated days after injection. each point represents 
the mean of five individual determinations.
Figure 2. Pathogenic pathways of rat and mice urinary bladder carcinogenesis (reviewed in ref. 3).
Table 1. Histopathological findings in the Sh instilled bladders and controls
Group n W N U I L M D
Group 1 (Sh treated) 10 20 7/10 (70%) 5/10 (50%) 9/10 (90%) 9/10 (90%) 0/10 (0%) 3/10 (30%)
Group 2 (Control) 10 20 10/10 (100%) 9/10 (90%) 2/10 (20%) 2/10 (20%) 0/10 (0%) 0/10 (0%)
Group 3 (Sh treated) 10 40 0/10 (0%) 0/10 (0%) 10/10 (100%) 9/10 (90%) 4/10 (40%) 7/10a (70%)
Group 4 (Control) 10 40 10/10 (100%) 10/10 (100%) 3/10 (30%) 3/10 (30%) 0/10 (0%) 0/10 (0%)
n, number of animals; W, weeks between treatment and sacrifice; n, normal urothelium; U, presence of umbrella cells; I, inflammatory infiltrate;  
L, infiltration of lymphocyte; M, infiltration of mastocytes; d, dysplasia; a(p = 0.001, Group 3 Vs. Group 4).
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this molecule related to estradiol is pres-
ent in schistosome worm extracts. In a first 
attempt, the detection method ELISA spe-
cific for estradiol, revealed the expression 
of this estradiol-related molecule in schis-
tosome worm extracts, but not in Fasciola 
hepatica worm extracts. We were able to 
characterize four estrogenic molecules. 
These molecules probably mediated an 
interaction between the parasites and their 
hosts, because their presence was detected 
in both organisms.
The quinone forms generated by meta-
bolic activation of catechol estrogens are 
highly electrophilic species. Some authors 
generated by metabolic activation of cate-
chol estrogens. In a first report, high levels 
of oestradiol but not LH, and Testosterone 
were detected in sera from urinary schis-
tosomiasis patients.8 This evidence was 
unexpected. Estradiol is a steroid hormone 
secreted principally by the ovarian fol-
licles in vertebrate animals. How could 
this be possible? The hormone levels in 
sera patients neither could nor be attrib-
uted to hypothalamic-pituitary-gonadal 
axis. How to explain this non sense bio-
logical evidence? The production of an 
estradiol-related molecule by Schistosoma 
was hypothesized. Finally, we show that 
for mutations in the Kras codon hotspots 
(12 and 13) gene. Two (out of 10) of the 
bladders with dysplasia presented a KRAS 
mutation in codon 12 of exon 2 (Fig. 4). 
We concluded from these results that the 
parasite extract of S. haematobium has car-
cinogenic ability possibly through onco-
genic mutation of KRAS gene.
Further investigations using Schistosoma 
haematobium antigens and the identifica-
tion of the carcinogenic component(s) may 
be useful to understand oncogenesis associ-
ated with this parasite. We have attempted 
to identify such carcinogenic compounds 
and they are probably quinone forms 
Figure 3. (A and B) control, (C) urothelium displaying an inflammatory nodule and a lesion with characteristics of nodular hyperplasia, (D) denuda-
tion and dysplasia, (E) inflammatory infiltrate and dysplasia, (F) inflammatory nodule and dysplasia.
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reported that these species are able to 
covalently bind DNA bases, forming 
stable adducts.9-12 These adducts can be 
considered as estrogen-bound metabolites 
generated in vivo that are produced by 
nucleophilic attack of the DNA base on 
different positions of the steroid ring.10-13 
Catechol estrogen-3,4-quinone adducts of 
DNA have been proposed as endogenous 
initiators of breast, prostate and other 
human cancers.14
The carcinogenic effect of this estrogen 
adduct-mediated pathway of the estro-
genic molecules present in S. haematobium 
extracts could explain the link between this 
parasite and squamous cell carcinoma of the 
bladder. More studies are ongoing aiming 
a better comprehension of these biological 
interactions and their carcinogenic effect.
Figure 4. KRAS exon 2 sequencing results. (A) control, (B) dysplastic bladder with a mutation at codon 12 (resulting in a Gly12Asp mutation).
